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Vitiligo is an acquired, circumscribed hypomelanotic
skin disorder, characterized by milky white patches due
to loss of functional melanocytes from the epidermis.
Prevalence of vitiligo is found to be very high in Gujarat
i.e., ~8.8%. Vitiligo is a multifactorial polygenic disorder
with a complex pathogenesis, linked with both genetic
and non-genetic factors. Several theories have been
proposed to explain the etiopathogenesis of vitiligo, but
none of the hypotheses explains the entire spectrum of
this disorder. We are addressing this complex disease in
our Gujarat population with various approaches. Our
study mainly deals with the evaluation of oxidative
stress, autoimmune, genetic and neurochemical hypoth-
eses in Gujarat vitiligo patients. We have shown that
our vitiligo patients exhibit significant oxidative stress
and thus, systemic oxidative stress could play a patho-
physiological role in precipitation of vitiligo in Gujarat
population. Our studies revealed that presence of
increased antimelanocyte antibodies and the imbalance of
T-cell (CD4+/CD8+ and Tregs) subsets along with their
functional defects might result in melanocyte destruction
in vitiligo patients. Our results on selected candidate genes
in conferring oxidative stress and autoimmunity suggest
that HLA-A*33:01, HLA-A*02:01,HLA-B*44:03, HLA-
DRB1*07:01 and a few studied polymorphisms in IL4,
CTLA4, SOD2, SOD3, GPX1, NALP1, MYG1, TNFA,
TNFB, IFNG and IL10 genes are strongly associated with
vitiligo susceptibility, whereas a few studied polymorph-
isms in PTPN22, MBL2, ACE, CAT, G6PD and SOD1
genes are not found to be significantly associated with
Gujarat vitiligo patients. Gene expression studies of the
IL4, CTLA4, SOD2, SOD3, NALP1, MYG1, TNFA, TNFB,
IFNG, IL10 and ICAM1 genes suggest that these genes are
strongly associated with vitiligo susceptibility. We are also
addressing the role of immune-regulatory genes with
respect to their expression in skin along with the effect of
selected cytokines on in vitro cultured melanocytes
derived from healthy and vitiliginous human skin to have
an insight towards vitiligo pathogenesis. We are also
exploring the potential microRNAs involved in pathogen-
esis of vitiligo. This integrated study will provide a better
understanding of the role played by oxidative stress and
autoimmunity in the pathogenesis of vitiligo in Gujarat
population and also to develop selective therapy and the
genetic marker/s for vitiligo.
Various factors such as the antioxidant status, LPO
(oxidative stress) levels and antimelanocyte antibody
titer decide the selective therapy for our vitiligo patients.
The pathogenesis of vitiligo though partially understood
still remains complex and enigmatic to a greater extent.
Though the condition may be precipitated by multiple
etiologies, the interaction of oxidative stress and
immune system clearly appears to be the key convergent
pathway that initiates and/or amplifies the enigmatic
loss of melanocytes in vitiligo.
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